» Articles » PMID: 40063732

Retraction: MicroRNA-216a Inhibits the Metastasis of Gastric Cancer Cells by Targeting JAK2/STAT3-mediated EMT Process

Overview
Journal Oncotarget
Specialty Oncology
Date 2025 Mar 10
PMID 40063732
Authors
Affiliations
Soon will be listed here.
References
1.
Pan T, Chen W, Yuan X, Shen J, Qin C, Wang L . miR-944 inhibits metastasis of gastric cancer by preventing the epithelial-mesenchymal transition via MACC1/Met/AKT signaling. FEBS Open Bio. 2017; 7(7):905-914. PMC: 5494292. DOI: 10.1002/2211-5463.12215. View

2.
Qu Y, Chen Q, Lai X, Zhu C, Chen C, Zhao X . SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1. Mol Cancer. 2014; 13:95. PMC: 4021559. DOI: 10.1186/1476-4598-13-95. View

3.
Sun M, Liu X, Lu K, Nie F, Xia R, Kong R . EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Cell Death Dis. 2014; 5:e1298. PMC: 4611729. DOI: 10.1038/cddis.2014.256. View

4.
Liu X, Yang L, Tu J, Cai W, Zhang M, Shou Z . microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma. Oncotarget. 2017; 8(50):87737-87749. PMC: 5675668. DOI: 10.18632/oncotarget.21209. View

5.
Sun M, Liu X, Wang K, Nie F, Kong R, Yang J . Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer. 2014; 13:68. PMC: 3998010. DOI: 10.1186/1476-4598-13-68. View